Some indicated impaired interferon (IFN) response with decreased IFN-α/β expression [60–62] while others showed enhanced type I IFN and pro-inflammatory reactions in severe COVID-19 patients [16, 63, 64]. This evidence concerns the gene IFNA1 and COVID-19.